C.diff Home

C.diff is an international observational study to estimate the 90-day response rates for several different antibiotic treatments for C. difficile infections in a cohort of solid organ and hematopoietic stem cell transplant patients. This includes treatment success, recurrence, and complications. Secondary objectives are to describe the clinical characteristics of C. difficile infections and to assess risk factors for outcomes over a 90-day follow-up period.

Protocol synopsis

Listing of sites

Participating countries

Protocol team

Community Advisory Board

INSIGHT C.diff ClinicalTrials.gov identifier: NCT02747017

INSIGHT C.diff EudraCT number: not applicable for this study